Clinical Trial

This DEA Marijuana Story Is So Bizarre and Twisted! Will President Trump Reschedule?

Following a landmark court ruling against the Department Of Labor, Duane Boise, CEO of MMJ International Holdings exposes the DEA's…

4 months ago

Medical Device Contract Manufacturing Market worth $140.84 billion by 2030 with 10.9% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Aug. 22, 2025 /PRNewswire/ -- The global Medical Device Contract Manufacturing Market, valued at US$78.58 billion in 2024, stood…

4 months ago

Bio-Thera and STADA Extend Biosimilars Alliance to Tocilizumab

Bio-Thera and STADA agree to extend their biosimilars alliance to cover tocilizumab, a targeted immunomodulatory monoclonal antibody directed against the…

4 months ago

Psyence Group Inc. Enters Into a Letter of Intent to Acquire Goldcoast Resource Corp.

TORONTO, ON / ACCESS Newswire / August 22, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), announces that…

4 months ago

Jyong Biotech Ltd. Participated in the 22nd Urological Association of Asia Congress to Display the Clinical Data for its Phase III Studies of BOTRESO and Phase II Study of MCS-8 (PCP)

New Taipei City, Taiwan, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a…

4 months ago

BlossomHill Therapeutics Announces First Patient Dosed in Expansion Cohorts of the Phase 1/2 SOLARA Trial, Evaluating BH-30643 in Advanced EGFR-mutant Non-Small Cell Lung Cancer

SAN DIEGO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design…

4 months ago

Gyre Therapeutics Announces the Appointment of Dan Weng, M.D., to Board of Directors

SAN DIEGO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to…

4 months ago

Harnessing the Power of Laboratory Data to Optimize Trial Design, Site Identification and Patient Recruitment, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how data-driven services can address the challenges that contributing factors raise in clinical trial design,…

4 months ago

SubjectWell Announces Steve Ciske as New Chief Technology Officer

AUSTIN, Texas, Aug. 21, 2025 /PRNewswire/ -- SubjectWell, the Patient Experience Platform driving predictable clinical trial enrollment and patient retention,…

4 months ago

IgniteData Appoints Dr. David Rhew, Global Chief Medical Officer of Microsoft, to Board of Directors

NEW CASTLE, Del., Aug. 21, 2025 /PRNewswire/ -- IgniteData, a leader in intelligent clinical trial data automation, is proud to announce…

4 months ago